Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

RP23-221K3.2 Inhibitors

RP23-221K3.2 inhibitors represent a class of small molecules or compounds designed to modulate the activity of the RP23-221K3.2 protein, which is typically involved in various intracellular signaling pathways. This protein is often categorized within the kinases, enzymes that play a crucial role in transferring phosphate groups from high-energy molecules like ATP to specific substrates. The process of phosphorylation is a critical biochemical mechanism that regulates numerous cellular functions, including gene expression, cell division, metabolism, and other essential signaling cascades. Inhibitors targeting RP23-221K3.2 act by disrupting its kinase activity, preventing the phosphorylation of its downstream targets, thereby altering the normal regulatory mechanisms within the cell. This inhibition can provide insights into the protein's natural role and help researchers understand the broader impacts of kinase regulation on complex intracellular processes.

The chemical structures of RP23-221K3.2 inhibitors are diverse, often containing functional groups that interact specifically with the ATP-binding domain or other regulatory regions of the kinase. Structural modifications of these inhibitors can fine-tune their specificity and potency, ensuring that they preferentially bind to RP23-221K3.2 without significantly affecting other kinases. The development of these inhibitors relies heavily on structure-activity relationship (SAR) studies, which correlate specific chemical changes in the inhibitor with biological activity. By focusing on the biophysical and biochemical properties of RP23-221K3.2 inhibitors, researchers can probe the dynamics of kinase-substrate interactions, offering valuable insights into the fundamental biological processes governed by these enzymes. The ability to precisely inhibit this protein also aids in mapping the extensive signaling networks it influences, contributing to our understanding of cellular behavior in various contexts.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D inhibits RNA synthesis by intercalating DNA, preventing OFD1 mRNA transcription.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide inhibits protein synthesis, potentially preventing the translation of OFD1 mRNA into the protein.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

5-Fluorouracil interferes with nucleotide synthesis, potentially disrupting the production of OFD1 mRNA.

Puromycin

53-79-2sc-205821
sc-205821A
10 mg
25 mg
$163.00
$316.00
436
(1)

Puromycin incorporates into peptide chains, potentially leading to premature termination of OFD1 protein synthesis.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin inhibits protein synthesis, potentially impacting the translation of OFD1 mRNA into the protein.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

Rifampicin inhibits bacterial RNA synthesis, which may indirectly impact OFD1 mRNA transcription in bacterial expression systems.

Benzo[a]pyrene

50-32-8sc-257130
1 g
$439.00
4
(1)

Thiolutin inhibits RNA synthesis, potentially preventing the transcription of OFD1 mRNA.

Blasticidin S Hydrochloride

3513-03-9sc-204655A
sc-204655
25 mg
100 mg
$360.00
$475.00
20
(2)

Blasticidin S inhibits protein synthesis, potentially preventing the translation of OFD1 mRNA into the protein.

Siomycin A

12656-09-6sc-202339
sc-202339-CW
sc-202339A
sc-202339B
500 µg
500 µg
2.5 mg
25 mg
$439.00
$449.00
$1326.00
$10200.00
4
(1)

Siomycin A inhibits RNA synthesis, potentially preventing the transcription of OFD1 mRNA.